A comparative gene expression matrix in Apoe-deficient mice identifies unique and atherosclerotic disease stage-specific gene regulation patterns in monocytes and macrophages.
暂无分享,去创建一个
B. Grüning | Clinton S. Robbins | P. Stachon | I. Hilgendorf | T. Heidt | B. Dufner | C. Härdtner | N. Hoppe | K. Krebs | C. Ehlert | C. Starz | L. Maegdefessel | Anup Kumar | D. Westermann | T. Dederichs | A. von Ehr | D. Wolf | Clinton S Robbins | C. von zur Mühlen | Tamara Vico | T. Vico
[1] M. Bader,et al. Role of Gpnmb in atherosclerosis of female mice. , 2022, Biochemical and biophysical research communications.
[2] M. Reilly,et al. Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization , 2021, Circulation.
[3] K. Ley,et al. Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe–/– mice , 2021, Molecular metabolism.
[4] C. Scavone,et al. The Role of GPNMB in Inflammation , 2021, Frontiers in Immunology.
[5] M. Kiss,et al. Haematopoetic TREM2 deficiency modulates atherosclerosis and lipid metabolism , 2020 .
[6] P. Kohl,et al. Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering , 2020, Basic Research in Cardiology.
[7] C. Glass,et al. Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics , 2020, Circulation research.
[8] J. Molkentin,et al. Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation , 2020, Nature Communications.
[9] Maxim N. Artyomov,et al. Limited proliferation capacity of aorta intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression , 2020, Nature Immunology.
[10] K. Moore,et al. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression , 2020, Circulation research.
[11] L. Willemsen,et al. Macrophage subsets in atherosclerosis as defined by single‐cell technologies , 2020, The Journal of pathology.
[12] R. Diaz,et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.
[13] Clint L. Miller,et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis , 2019, Nature Medicine.
[14] Qingbo Xu,et al. Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[15] S. Ramsey,et al. Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression. , 2019, JCI insight.
[16] Maxim N. Artyomov,et al. Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models , 2018, Circulation research.
[17] W. Ling,et al. Apoptotic cell induction of miR-10b in macrophages contributes to advanced atherosclerosis progression in ApoE−/− mice , 2018, Cardiovascular research.
[18] Dennis Wolf,et al. Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry , 2018, Circulation research.
[19] Dennis Wolf,et al. Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis , 2018, Circulation research.
[20] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[21] T. Renné,et al. MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions , 2017, Circulation research.
[22] K. Bornfeldt,et al. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. , 2016, Circulation research.
[23] P. Libby,et al. Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression , 2016, Basic Research in Cardiology.
[24] Clinton S. Robbins,et al. Monocyte fate in atherosclerosis. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[25] Christian Stolte,et al. COMPARTMENTS: unification and visualization of protein subcellular localization evidence , 2014, Database J. Biol. Databases Curation.
[26] P. Libby,et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis , 2013, Nature Medicine.
[27] F. Ginhoux,et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. , 2013, Immunity.
[28] A. Mildner,et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.
[29] Andrew C. Li,et al. Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses , 2012, Cell.
[30] P. Libby. Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[31] F. Geissmann,et al. Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.
[32] H. Itabe. Oxidative Modification of LDL: Its Pathological Role in Atherosclerosis , 2009, Clinical reviews in allergy & immunology.
[33] P. Libby,et al. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.
[34] M. Febbraio,et al. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. , 2008, Cardiovascular research.
[35] P. Libby,et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease , 2006, Proceedings of the National Academy of Sciences.
[36] G. Hansson,et al. Inflammation and atherosclerosis. , 2006, Annual review of pathology.
[37] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[38] K. Moore,et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.
[39] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[40] Z. Galis,et al. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. , 2002, The American journal of pathology.
[41] M. Jaye,et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.
[42] Andrew C. Li,et al. Polymerase Chain Reaction–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo Enhancement by Tumor Necrosis Factor-α and Interleukin-1β , 2000 .
[43] P. Casellas,et al. lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses , 1993, Nature.
[44] H. Aburatani,et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.